Clinical trial
Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in…
NCT00223938 · Sanofi, Industry · Terminated
Key facts
| NCT number | NCT00223938 |
|---|---|
| Title | Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients. |
| Official title | A Multi-center, Open-label, Randomized, Parallel Group Study of the Efficacy and Safety of Ferrlecit in the Maintenance of Iron Stores and Serum Hemoglobin Concentration in Hemodialysis Patients Receiving Erythropoietin. |
| Lead sponsor | Sanofi, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Oral Iron, sodium ferric gluconate |
| Enrollment | 112 |
| Start date | Dec 30, 2003 |
| Primary completion | Apr 27, 2007 |
| Completion | Apr 27, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 24, 2021 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: